Coast-to-Coast Specialized Preclinical Solutions
Four Preclinical Sites to Support Your Program
With four purpose-built preclinical facilities across the U.S., we conduct over 700 safety assessment studies annually in rodent and non-rodent species. Our small and large molecule solutions include pivotal toxicology, safety pharmacology, and PK/PD studies, with comprehensive bioanalytical services to ensure your IND submissions meet global regulatory requirements.
Our specialties include:
- Therapeutic Indications
- ophthalmology
- dermatology
- CNS research
- Therapeutic Products
- cell and gene therapy
- oligonucleotides
- monoclonal antibodies
- antibody-drug conjugates
Learn more about the specific capabilities provided at each of our preclinical facilities.
Questions on how we can support your drug development program? Consult with one of our experts.
Related resources that may interest you:
- Webpage: Comprehensive Preclinical Drug Development Solutions
- Scientific Article: Navigating the IND Submission Process
- Webinar: How to Select the Right Species for Your Nonclinical Program